The beneficial effects of statins in patients undergoing hemodialysis

Chin-Chou Huang1, Wan-Leong Chan, Yu-Chun Chen

  • 1Department of Medical Research and Education, Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C.; Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C.; Cardiovascular Research Center, National Yang-Ming University, Taipei, Taiwan, R.O.C.; Institute of Pharmacology, National Yang-Ming University, Taipei, Taiwan, R.O.C.

Insights

Statin use significantly reduced cardiovascular events and mortality in hemodialysis patients. This study demonstrates statins

Area of Science:

  • Nephrology
  • Cardiology
  • Pharmacology

Background:

  • The efficacy of statin therapy in patients undergoing hemodialysis remains a subject of debate.
  • Cardiovascular disease is a leading cause of mortality in patients with end-stage renal disease requiring hemodialysis.

Purpose of the Study:

  • To evaluate the association between statin use and the risk of cardiovascular morbidity and mortality in hemodialysis patients.

Main Methods:

  • A cohort study utilized data from the Taiwan National Health Insurance Research Database.
  • Cox regression analysis was employed to compare outcomes between statin users and propensity-matched non-users undergoing hemodialysis.

Main Results:

  • The statin cohort (4074 patients) exhibited significantly lower incidences of ischemic stroke, unstable angina, deep vein thrombosis, cardiovascular mortality, and all-cause mortality compared to the non-statin cohort (8148 patients).
  • Statin use was independently associated with reduced risks for ischemic stroke (HR, 0.49), unstable angina hospitalization (HR, 0.57), deep vein thrombosis (HR, 0.11), cardiovascular mortality (HR, 0.29), and all-cause mortality (HR, 0.49).

Conclusions:

  • Statin therapy is associated with a significant reduction in cardiovascular morbidity and mortality among patients undergoing hemodialysis.
  • These findings support the consideration of statin use in hemodialysis patients to mitigate cardiovascular risks.
Abstract

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...